Cyxtera to Speak at Upcoming Investor Conferences

Cyxtera (NASDAQ: CYXT), a leader in data center colocation and interconnection, announced participation in two investor conferences on December 5, 2022.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

conferences

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

11/30/2022 - 04:15 PM EST

MIAMI--(BUSINESS WIRE)-- Cyxtera (NASDAQ: CYXT), a global leader in data center colocation and interconnection services, today announced that Carlos Sagasta, Chief Financial Officer, will participate in two upcoming investor conferences:

Raymond James Technology Investors Conference: Data center panel discussion on Monday, December 5, 2022, at 9:45 a.m. ET
UBS Global TMT Conference: Fireside chat on Monday, December 5, 2022, at 1:20 p.m. ET

The presentations will be made available via webcast on the Investor Relations section of the Cyxtera website at https://ir.cyxtera.com.

About Cyxtera

Cyxtera is a global leader in colocation and interconnection services, with a footprint of more than 60 data centers in over 30 markets. With IT infrastructure becoming increasingly hybrid, complex, and distributed, Cyxtera continues to expand its portfolio beyond space and power to deliver more cloud-like and flexible infrastructure solutions across its global data center platform and robust partner ecosystem. Today, Cyxtera provides more than 2,300 enterprise and government customers with the technology solutions they need to scale faster, achieve financial goals, and gain a competitive advantage. For more information, please visit www.cyxtera.com.